The HASTINGS CENTER REPORT, published by WILEY, is a leading journal in the fields of bioethics, health policy, and the philosophical underpinnings of healthcare. Established in 1971, this influential publication provides a critical platform for the discussion of ethical issues in health, medicine, and biotechnology, highlighting the intersection between ethical theory and practical health challenges. The journal achieves remarkable academic stature, achieving Q1 rankings in both Issues, Ethics and Legal Aspects and Philosophy, alongside Q2 standings in Health Policy and Health (social science) categories, reflecting its broad interdisciplinary impact. With its wide readership and rigorous peer-review process, the HASTINGS CENTER REPORT serves as an essential resource for researchers, practitioners, and students dedicated to advancing ethical perspectives in health-related discourse. While the journal operates under traditional access options, its contributions resonate deeply within the academic community, fostering informed dialogue on pressing ethical dilemmas and policy considerations in a rapidly evolving healthcare landscape.

Revista Colombiana de Bioetica, an esteemed publication under the auspices of UNIV EL BOSQUE, serves as a pivotal platform in the interdisciplinary field of bioethics, offering insights and scholarly discourse relevant to researchers, professionals, and students alike. With an ISSN of 1900-6896 and an E-ISSN of 2590-9452, this open access journal, available since 2010, champions the democratization of knowledge, ensuring that vital research is accessible to all. Nestled in Bogotá, Colombia, the journal's commitment to ethical inquiry and critical thinking in biomedical and health-related disciplines positions it as a crucial resource for those keen on exploring the intersections of ethics, law, philosophy, and health sciences. By facilitating the exchange of innovative ideas and research, the Revista Colombiana de Bioetica aspires to inspire informed dialogue and foster ethical practices within the scientific community and beyond.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

Developing World Bioethics, published by WILEY, is an esteemed journal dedicated to the exploration and advancement of ethical issues in health and healthcare within developing countries. Since its inception in 2001, this journal has become a critical platform for disseminating scholarly research and discourse that address complex bioethical challenges in varied socio-economic contexts. With an impressive Q2 ranking in multiple categories, including Health Policy and Issues, Ethics and Legal Aspects, it stands out as a vital resource among its peers, boasting significant Scopus rankings that highlight its influence and contribution to the fields of health and social sciences. The journal is committed to fostering interdisciplinary dialogue and insight, making it an invaluable asset for researchers, professionals, and students keen on bioethics and health policy. While the journal operates on a subscription basis, it provides broad access to its diverse range of articles, ensuring that cutting-edge bioethical perspectives are available to stakeholders worldwide, with a focus on innovative solutions and best practices in healthcare systems globally.

HEALTH CARE ANALYSIS, published by SPRINGER, is a distinguished journal that has been contributing to the field of Health Policy and related disciplines since its inception in 1993. With a significant focus on the intricate issues, ethics, and legal aspects surrounding healthcare, this journal holds a prominent status reflected in its Q2 rankings across various categories, including Health Policy, Health (social science), and Issues, Ethics and Legal Aspects. As of 2023, it ranks in the top quartiles of its respective fields, indicating robust scholarly engagement and impact within the academic community. Although the journal is not open access, it remains accessible to a wide audience through institutional subscriptions, making it an essential resource for researchers, healthcare professionals, and policy-makers seeking to advance their understanding of complex healthcare systems and ethical considerations. Positioned in the Netherlands, HEALTH CARE ANALYSIS continues to drive critical dialogue and research, ensuring its relevance in shaping future healthcare policies and practices.

Journal of Ethics is a premier academic journal devoted to the exploration and analysis of ethical theories and practices within various disciplines. Published by SPRINGER in the Netherlands, this prestigious journal has established itself within the field of Philosophy, boasting a commendable Q1 classification in the 2023 category quartiles. With an impressive Scopus rank of 145 out of 806 in the Arts and Humanities sector, it occupies the 82nd percentile, indicating its significant impact and reach. The journal aims to provide a platform for rigorous discussion and research that addresses contemporary ethical issues, making it an essential resource for researchers, professionals, and students alike. Although not an Open Access journal, it offers various access options to ensure that critical insights and scholarly contributions are disseminated widely.

JOURNAL OF MEDICAL ETHICS, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that has been pivotal in advancing the discourse on ethical issues in healthcare since its inception in 1975. This UK-based journal, with an ISSN of 0306-6800 and an E-ISSN of 1473-4257, is well-regarded for its high-quality, peer-reviewed articles that delve into the complex moral dimensions surrounding medical practices, health policies, and social sciences. With a commendable impact, JOURNAL OF MEDICAL ETHICS has achieved Q1 quartile rankings across multiple categories, including Arts and Humanities and Health Policy in 2023, reflecting its significant influence and relevance in the field—ranked #23 of 552 in Arts and Humanities (Miscellaneous) with a 95th percentile, and #26 in Health Policy with a 91st percentile. Researchers, professionals, and students alike can benefit from the journal's commitment to fostering a deeper understanding of ethical considerations vital to the medical community, although it currently does not offer open access options. The journal's comprehensive examination of issues, ethics, and legal aspects continues to make it an essential resource for those dedicated to shaping the ethical landscape of healthcare.

The Journal of Moral Philosophy is a prestigious scholarly publication dedicated to the exploration and analysis of ethical theories and moral frameworks. Published by BRILL in the Netherlands, this journal has established itself as a leading voice in the field, currently holding an impressive Q1 ranking in Philosophy for 2023 and positioned in the 75th percentile among similar publications in the Scopus Arts and Humanities category. Since its inception in 2004 and continuing through 2024, the journal seeks to provide a platform for rigorous philosophical inquiry, featuring original research articles, comprehensive reviews, and critical discussions that foster dialogue among scholars. Despite it not being open access, the journal maintains a strong commitment to advancing philosophical thought and engaging the academic community, making it an essential resource for researchers, professionals, and students aspiring to deepen their understanding of moral philosophy.

BMC Medical Ethics is a leading open-access journal dedicated to the critical exploration and dissemination of knowledge surrounding ethical issues in healthcare and medicine. Published by BMC, and headquartered in the United Kingdom, this journal has become a cornerstone in the field since its inception in 2000, with a remarkable focus on health policy, nursing ethics, and the complex legal aspects intertwining with healthcare practices. With an impressive Q1 ranking across multiple categories, including Health Policy and Health (Social Science), it ranks among the top journals globally—particularly notable with its Scopus rankings reflecting a strong 85th percentile in Nursing and an 81st percentile in Social Sciences. As an open-access publication, BMC Medical Ethics ensures that research findings are readily accessible, fostering a collaborative environment for researchers, practitioners, and students alike. The journal's commitment to ethical discourse not only advances academic inquiry but also shapes the practices and policies that govern healthcare delivery; thus, making it an invaluable resource for those engaged in the advancement of medical ethics.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.